These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4679895)

  • 41. Quantitative observations on mineralised and unmineralised bone in chronic renal azotaemia and intestinal malabsorption syndrome.
    Garner A; Ball J
    J Pathol Bacteriol; 1966 Apr; 91(2):545-61. PubMed ID: 5918626
    [No Abstract]   [Full Text] [Related]  

  • 42. Uremic osteodystrophy.
    Prat J; Osborne RL
    Clin Bull; 1976; 6(3):121-4. PubMed ID: 1000788
    [No Abstract]   [Full Text] [Related]  

  • 43. [Bone changes in chronic renal diseases].
    Kontek M; Raszeja-Wanic B
    Pol Arch Med Wewn; 1971 Oct; 47(4):343-50. PubMed ID: 5159660
    [No Abstract]   [Full Text] [Related]  

  • 44. Renal osteodystrophy in end-stage renal failure.
    Nortman DF; Coburn JW
    Postgrad Med; 1978 Nov; 64(5):123-30. PubMed ID: 714829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteodystrophy in experimental uremia.
    Mehls O; Ritz E; Gilli G; Wingen AM
    Contrib Nephrol; 1988; 60():207-13. PubMed ID: 3345670
    [No Abstract]   [Full Text] [Related]  

  • 46. Update on renal osteodystrophy: pathogenesis and clinical management.
    Sakhaee K; Gonzalez GB
    Am J Med Sci; 1999 Apr; 317(4):251-60. PubMed ID: 10210362
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparative clinical and histomorphological studies on the therapy of renal osteopathy using vitamin D and 5,6-trans-25-OHCC].
    Schulz W; Heidler R; Gessler U; Offermann G; Schulz A; Delling G
    Verh Dtsch Ges Inn Med; 1975; 81():976-80. PubMed ID: 1229631
    [No Abstract]   [Full Text] [Related]  

  • 48. Pathogenesis and histology of renal osteodystrophy.
    Malluche HH; Langub MC; Monier-Faugere MC
    Osteoporos Int; 1997; 7 Suppl 3():S184-7. PubMed ID: 9536329
    [No Abstract]   [Full Text] [Related]  

  • 49. Hemodialysis bone disease: correlation between clinical, histologic, and other findings.
    Alvarez-Ude F; Feest TG; Ward MK; Pierides AM; Ellis HA; Peart M; Simpson W; Weightman D; Kerr DN
    Kidney Int; 1978 Jul; 14(1):68-73. PubMed ID: 682426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone crystal maturation in renal osteodystrophy in humans.
    Burnell JM; Teubner E; Wergedal JE; Sherrard DJ
    J Clin Invest; 1974 Jan; 53(1):52-8. PubMed ID: 4808647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum bone gla-protein compared to bone histomorphometry in hemodialyzed patients.
    Charhon SA; Delmas PD; Malaval L; Chavassieux PM; Chapuy MC; Meunier PJ
    Adv Exp Med Biol; 1986; 208():291-6. PubMed ID: 3494387
    [No Abstract]   [Full Text] [Related]  

  • 52. Natural course of secondary hyperparathyroidism after successful renal transplantation.
    Roof BS; Piel CF; Carpenter BJ; Gordan GS; Kountz S; Belzer F
    Proc Clin Dial Transplant Forum; 1971; 1():11-20. PubMed ID: 4951041
    [No Abstract]   [Full Text] [Related]  

  • 53. [Experimental studies on the pathogenesis of osteopathy in uremia].
    Krempien B; Ritz E
    Verh Dtsch Ges Inn Med; 1971; 77():249-52. PubMed ID: 4265146
    [No Abstract]   [Full Text] [Related]  

  • 54. [Parathormone as a uremic toxin. Physiopathological bases and general therapeutic guidelines].
    Brancaccio D; Galmozzi C; Pizzocaro G
    Minerva Med; 1985 Mar; 76(9-10):377-82. PubMed ID: 3982693
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical conference: Hyperparathyroidism.
    Am J Med; 1973 Nov; 55(5):657-66. PubMed ID: 4270677
    [No Abstract]   [Full Text] [Related]  

  • 56. Renal osteodystrophy: pathophysiology and treatment.
    Fournier A; Sebert JL; Moriniere P; Gregoire I; de Fremont JF; Tahiri Y; Dkhissi H
    Horm Res; 1984; 20(1):44-58. PubMed ID: 6378747
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinico-morphological correlations in uremic osteodystrophy of patients with conservative and hemodialytic treatment with special regard to the ultrastructure].
    Bonucci E; Gherardi G; Mioni G; Castellani A; Cecchettin M; Cristinelli L; Migozzi G; Maiorca R; Maschio G; D'Angelo A; Ossi E; Lupo A; Valvo E
    Minerva Nefrol; 1975; 22(2-3):99-108. PubMed ID: 1226257
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prevention and treatment of renal osteodystrophy: present and future].
    Fernández E; Craver L
    Nefrologia; 2006; 26 Suppl 3():19-27. PubMed ID: 17469423
    [No Abstract]   [Full Text] [Related]  

  • 59. Morphological effects of vitamin D and its analogs on bone.
    Teitelbaum SL
    Am J Clin Nutr; 1976 Nov; 29(11):1300-6. PubMed ID: 998541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteomalacia in patients with chronic renal failure before dialysis or transplantation.
    Mora Palma FJ; Ellis HA; Cook DB; Dewar JH; Ward MK; Wilkinson R; Kerr DN
    Q J Med; 1983; 52(207):332-48. PubMed ID: 6647748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.